Exploring the effects of a different posttranslational modification, Krug et al have recently reported that IFNGR expression is regulated in human CRC cells through N-glycosylation, which targets it for proteasome-dependent degradation and thus decreases protein stability. This evidence concerns the gene IFNGR1 and colorectal carcinoma.